News

Keeping Communities Safe

The ThinkFirst chapter at SIU School of Medicine was awarded the ThinkFirst Chapter of the Year Award at the Annual National ThinkFirst Conference this summer.
News

Keeping Communities Safe

The ThinkFirst chapter at SIU School of Medicine was awarded the ThinkFirst Chapter of the Year Award at the Annual National ThinkFirst Conference this summer.
News

Keeping Communities Safe

The ThinkFirst chapter at SIU School of Medicine was awarded the ThinkFirst Chapter of the Year Award at the Annual National ThinkFirst Conference this summer.
Trial
Neuroscience Institute

Sleep for Stroke Management and Recovery Trial

Active recruiting

The primary goals of this study are to determine whether treatment of obstructive sleep apnea with positive airway pressure starting shortly after accute ischemic stroke or high risk TIA (1) reduces recurrent stroke, acute coronary syndrome, and all-cause mortality 6 months after the event and (2) improves stroke outcomes at 3 months in patients who experienced ischemic stroke.

Trial
Neuroscience Institute

18-513: A Randomized Clinical Trial of Andexanet Alfa in Acute Intracranial Hemorrhage in Patients Receiving an Oral Factor XA Inhibitor

Active not recruiting

18-513:  The purpose of this study is to evaluate the effect of andexanet alfa (andexanet) versus usual care on the rate of effective homostasis.

Trial
Urology

ProVIDE: The ProVee Urethral Expander System Study: The ProVee IDE Study

Active not recruiting

The study will test whether the study device, the ProVee Urethral Expander System, can be placed in your urethra safely to treat your urinary symptoms due to your enlarged prostate.

Trial
Psychiatry

ImpactTD Registry: A prospective multicenter study to characterize the natural history of tardive dyskinesia (TD) and investigate the real-world effectiveness of deutetrabenazine on the multidimensional impact of TD

Active recruiting

TV50717-CNS-40223: The purpose of this study is to get a better understanding of the disease course of tardive dyskinesia and the impact it has on individuals’ lives. In subjects who may begin on deutetrabenazine (AUSTEDO®) treatment during the study, it will also help investigate the real-world effectiveness of this treatment, particularly on a person’s quality of life.

Trial
Psychiatry

Click: Study to Evaluate the Efficacy and Safety of a Digital Therapeutic as an Adjunct to Standard-of-Care Antipsychotic Therapy in Adult and Late Adolescent Participants with Experiential Negative Symptoms of Schizophrenia

Active recruiting

CT-155-R-001: The purpose of this study is to investigate if digital therapeutics (a moblie software application) can help treat certain symptoms of schizophrenia. 

General Results

Resident Benefit Information

Alton Based Resident Information Carbondale Based Resident Information Decatur Based Resident Information Quincy Based Resident Information Springfield Based Resident Information
News

Adams research efforts earn 2022 Toth Award

The Research Policy Committee honored Kristal Adams with the 2022 Frank J. Toth Award, the highest recognition for SIU School of Medicine research support personnel. Adams is a clinical research program director in the Center for Clinical Research.
Subscribe to